{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T19:49:43Z","timestamp":1714420183658},"reference-count":18,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.remn.2011.06.001","type":"journal-article","created":{"date-parts":[[2011,8,8]],"date-time":"2011-08-08T19:17:04Z","timestamp":1312831024000},"page":"257-260","source":"Crossref","is-referenced-by-count":2,"title":["The value of FDG-PET\/CT in the post-treatment evaluation of endometrial carcinoma: A comparison of PET\/CT findings with conventional imaging and CA 125 as a tumour marker"],"prefix":"10.1016","volume":"31","author":[{"given":"P.","family":"Ozcan Kara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Kara","family":"Gedik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remn.2011.06.001_bib0005","first-page":"173","article-title":"Advances in the management of endometrial adenocarcinoma. A review","volume":"47","author":"Irvin","year":"2002","journal-title":"J Reprod Med"},{"key":"10.1016\/j.remn.2011.06.001_bib0010","first-page":"315","article-title":"The value of serum CA 125 and association CA 125\/CA 19-9 in endometrial carcinoma","volume":"20","author":"Cherchi","year":"1999","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.remn.2011.06.001_bib0015","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s00259-002-0878-2","article-title":"Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma","volume":"29","author":"Belhocine","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2011.06.001_bib0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF02990022","article-title":"Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer","volume":"17","author":"Saga","year":"2003","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.remn.2011.06.001_bib0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00259-005-1876-y","article-title":"18F-FDG PET in the management of endometrial cancer","volume":"33","author":"Chao","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2011.06.001_bib0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12149-007-0087-y","article-title":"Performance of FDG-PET\/CT in the diagnosis of recurrent endometrial cancer","volume":"22","author":"Kitajima","year":"2008","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.remn.2011.06.001_bib0035","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00259-008-0956-1","article-title":"Performance of integrated FDG-PET\/contrast-enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT","volume":"36","author":"Kitajima","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2011.06.001_bib0040","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.2214\/AJR.07.3372","article-title":"Accuracy of 18F-FDG-PET\/CT in detecting pelvic and paraaortic lymph node metastasis in patients with endometrial cancer","volume":"190","author":"Kitajima","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.remn.2011.06.001_bib0045","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00259-006-0251-y","article-title":"Post-therapy surveillance of patients with uterine cancers: value of integrated FDG-PET\/CT in the detection of recurrence","volume":"34","author":"Sironi","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2011.06.001_bib0050","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/j.1525-1438.2008.01197.x","article-title":"Clinical impact of positron emission tomography or positron emission tomography\/computed tomography in the posttherapy surveillance of endometrial carcinoma: evaluation of 88 patients","volume":"18","author":"Park","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.remn.2011.06.001_bib0055","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00259-007-0687-8","article-title":"The clinical impact of [(18)F]FDG-PET\/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings","volume":"35","author":"Chung","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remn.2011.06.001_bib0060","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.remn.2011.06.001_bib0065","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.remn.2011.06.001_bib0070","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","article-title":"Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group","volume":"35","author":"Young","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.remn.2011.06.001_bib0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/gyno.1994.1093","article-title":"What is a normal CA125 level?","volume":"53","author":"Alagoz","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.remn.2011.06.001_bib0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/gyno.1998.5018","article-title":"Determination of a normal level of serum CA125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma","volume":"69","author":"Kurihara","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.remn.2011.06.001_bib0085","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S1701-2163(16)34657-6","article-title":"Reoperative CA 125 tumour marker in endometrial cancer: correlation with advanced stage disease","volume":"32","author":"Sebastianelli","year":"2010","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.remn.2011.06.001_bib0090","first-page":"12","article-title":"Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma","volume":"84","author":"Rose","year":"1994","journal-title":"Obstet Gynecol"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698211001856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0212698211001856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T15:57:47Z","timestamp":1543593467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0212698211001856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0212698211001856"],"URL":"https:\/\/doi.org\/10.1016\/j.remn.2011.06.001","relation":{},"ISSN":["2253-654X"],"issn-type":[{"value":"2253-654X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}